iRhythm Holdings (IRTC) Cash from Investing Activities Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 179.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.22% |
| Dec 31, 2025 | 60.05% |
| Sep 30, 2025 | -61.21% |
| Jun 30, 2025 | -795.39% |
| Mar 31, 2025 | -195.35% |
| Dec 31, 2024 | -8,825.64% |
| Sep 30, 2024 | -258.43% |
| Jun 30, 2024 | 61.08% |
| Mar 31, 2024 | 947.07% |
| Dec 31, 2023 | 117.25% |
| Sep 30, 2023 | 56.34% |
| Jun 30, 2023 | 2,190.26% |
| Mar 31, 2023 | 144.80% |
| Dec 31, 2022 | 70.10% |
| Sep 30, 2022 | -358.87% |
| Jun 30, 2022 | -125.32% |
| Mar 31, 2022 | -107.29% |
| Dec 31, 2021 | -55.18% |
| Sep 30, 2021 | 106.68% |
| Jun 30, 2021 | -94.26% |
| Mar 31, 2021 | 95.35% |
| Dec 31, 2020 | -39.79% |
| Sep 30, 2020 | -134.87% |
| Jun 30, 2020 | 284.45% |
| Mar 31, 2020 | 127.12% |
| Dec 31, 2019 | -391.29% |
| Sep 30, 2019 | -5,263.88% |
| Jun 30, 2019 | -339.92% |
| Mar 31, 2019 | 22.93% |
| Dec 31, 2018 | 141.00% |
| Sep 30, 2018 | -72.55% |
| Jun 30, 2018 | 1,118.69% |
| Mar 31, 2018 | 172.26% |
| Dec 31, 2017 | 84.22% |
| Sep 30, 2017 | 916.76% |
| Jun 30, 2017 | -60.49% |
| Mar 31, 2017 | -4,406.22% |
| Dec 31, 2016 | -25,030.68% |